Brazil · Delayed Price · Currency is BRL Dexco Statistics
Total Valuation
Dexco has a market cap or net worth of BRL 4.16 billion. The enterprise value is 10.80 billion.
| Market Cap | 4.16B |
| Enterprise Value | 10.80B |
Important Dates
The last earnings date was Wednesday, March 4, 2026.
| Earnings Date | Mar 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Dexco has 907.65 million shares outstanding. The number of shares has increased by 1.10% in one year.
| Current Share Class | 907.65M |
| Shares Outstanding | 907.65M |
| Shares Change (YoY) | +1.10% |
| Shares Change (QoQ) | +3.19% |
| Owned by Insiders (%) | 19.49% |
| Owned by Institutions (%) | 32.31% |
| Float | 339.30M |
Valuation Ratios
The trailing PE ratio is 3,516.97 and the forward PE ratio is 10.07. Dexco's PEG ratio is 0.08.
| PE Ratio | 3,516.97 |
| Forward PE | 10.07 |
| PS Ratio | 0.50 |
| PB Ratio | 0.58 |
| P/TBV Ratio | 0.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 4.89 |
| PEG Ratio | 0.08 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.47, with an EV/FCF ratio of -178.97.
| EV / Earnings | 9,133.56 |
| EV / Sales | 1.31 |
| EV / EBITDA | 5.47 |
| EV / EBIT | 14.46 |
| EV / FCF | -178.97 |
Financial Position
The company has a current ratio of 2.24, with a Debt / Equity ratio of 1.24.
| Current Ratio | 2.24 |
| Quick Ratio | 1.55 |
| Debt / Equity | 1.24 |
| Debt / EBITDA | 5.11 |
| Debt / FCF | -148.40 |
| Interest Coverage | 0.57 |
Financial Efficiency
Return on equity (ROE) is 0.88% and return on invested capital (ROIC) is 3.87%.
| Return on Equity (ROE) | 0.88% |
| Return on Assets (ROA) | 1.76% |
| Return on Invested Capital (ROIC) | 3.87% |
| Return on Capital Employed (ROCE) | 3.21% |
| Weighted Average Cost of Capital (WACC) | 7.61% |
| Revenue Per Employee | 579,755 |
| Profits Per Employee | 83 |
| Employee Count | 14,228 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 3.73 |
Taxes
| Income Tax | -151.27M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.67% in the last 52 weeks. The beta is 0.42, so Dexco's price volatility has been lower than the market average.
| Beta (5Y) | 0.42 |
| 52-Week Price Change | -8.67% |
| 50-Day Moving Average | 5.30 |
| 200-Day Moving Average | 5.03 |
| Relative Strength Index (RSI) | 36.85 |
| Average Volume (20 Days) | 3,517,440 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dexco had revenue of BRL 8.25 billion and earned 1.18 million in profits. Earnings per share was 0.00.
| Revenue | 8.25B |
| Gross Profit | 1.90B |
| Operating Income | 523.92M |
| Pretax Income | -88.21M |
| Net Income | 1.18M |
| EBITDA | 1.67B |
| EBIT | 523.92M |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 2.53 billion in cash and 8.95 billion in debt, with a net cash position of -6.28 billion or -6.92 per share.
| Cash & Cash Equivalents | 2.53B |
| Total Debt | 8.95B |
| Net Cash | -6.28B |
| Net Cash Per Share | -6.92 |
| Equity (Book Value) | 7.21B |
| Book Value Per Share | 7.54 |
| Working Capital | 3.35B |
Cash Flow
In the last 12 months, operating cash flow was 850.65 million and capital expenditures -910.97 million, giving a free cash flow of -60.32 million.
| Operating Cash Flow | 850.65M |
| Capital Expenditures | -910.97M |
| Depreciation & Amortization | 1.14B |
| Net Borrowing | 899.84M |
| Free Cash Flow | -60.32M |
| FCF Per Share | -0.07 |
Margins
Gross margin is 23.04%, with operating and profit margins of 6.35% and 0.01%.
| Gross Margin | 23.04% |
| Operating Margin | 6.35% |
| Pretax Margin | -1.07% |
| Profit Margin | 0.01% |
| EBITDA Margin | 20.21% |
| EBIT Margin | 6.35% |
| FCF Margin | n/a |
Dividends & Yields
Dexco does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 3,852.37% |
| Buyback Yield | -1.10% |
| Shareholder Yield | -1.10% |
| Earnings Yield | 0.03% |
| FCF Yield | -1.45% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 26, 2025. It was a forward split with a ratio of 1.12.
| Last Split Date | Dec 26, 2025 |
| Split Type | Forward |
| Split Ratio | 1.12 |
Scores
Dexco has an Altman Z-Score of 1.07 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.07 |
| Piotroski F-Score | 5 |